Skip to main content
TipRanks
Go Ultimate75% OFF

C Boyd Clarke Insider Profile

4 Followers

C Boyd Clarke, Chief Executive Officer at UBS Group AG, holds 6.00K shares in UBS Group AG (Ticker: UBS), holds 75.45K shares in Novelion Therapeutics (Ticker: NVLNF).

C Boyd Clarke's Trading History

NVLNF
Novelion Therapeutics
―――$52.97K
UBS
UBS Group AG
―Chief Executive Officer―$285.66K

You May Also Like

C Boyd Clarke insider profile FAQ

What is the percentage of profitable transactions made by C Boyd Clarke?
The percentage of profitable transactions made by C Boyd Clarke is 100%.
What is the average return per transaction made by C Boyd Clarke?
The average return per transaction made by C Boyd Clarke is 103.40%.
What stocks does C Boyd Clarke hold?
C Boyd Clarke holds: UBS, NVLNF stocks.
What is C Boyd Clarke's role in UBS Group AG?
C Boyd Clarke's role in UBS Group AG is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.